CoChat

Biopsy-diagnosed renal granuloma after intravesical bacillus Calmette-Guérin therapy for bladder carcinoma: a case series and review of the literature

Open access

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

Renal granuloma is a rare complication affecting the kidneys after intravesical bacillus Calmette-Guérin (BCG) therapy for bladder carcinoma. Our case series review describes the imaging and histopathological findings of BCG-induced renal granulomas. All three renal granulomas, which were located in the upper pole, had a solitary mass-like appearance. The mean diameter was 31.3 mm. In the two cases, the lesion was homogeneously enhanced on post-contrast CT, and presented homogeneous low signal intensity on T 2 weighted imaging (T 2 WI) and iso-signal intensity on diffusion-weighted imaging (DWI). Both lesions had increased fludeoxyglucose (FDG) uptake. Histological examinations revealed granulomatous inflammation with fibrosis. The third case showed a lesion having heterogeneous enhancement on CT, heterogeneous and slightly high signal intensity on T 2 WI, and high signal intensity on DWI. This case showed more severe inflammatory cell infiltration and less fibrosis than the former two cases did. It was suggested that the signal intensity on T 2 WI and DWI depends on the degree of inflammation and fibrosis in renal granuloma. It is currently challenging to distinguish renal granuloma from renal malignancy based on only imaging findings. Biopsies were helpful in confirming the diagnosis and avoiding unnecessary resection. Renal granuloma should be considered as a differential diagnosis when a renal mass is found in a patient with a history of intravesical BCG treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1259/bjrcr.20190012

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Case 1: Renal granuloma developing after intravesical bacillus Calmette-Guérin treatment for bladder carcinoma in a 73-year-old male. (a) An axial unenhanced CT image revealing an iso-attenuating mass (37 HU), compared to the renal parenchyma. (b–d) Dynamic contrast-enhanced CT findings showed a gradually enhanced renal mass. The CT attenuation value was 47 HU during the corticomedullary phase (b), 87 HU during the nephrographic phase (c), and 90 HU during the early excretory phase (d). (e) An axial T2 weighted image presenting low signal intensity for the renal lesion on the left kidney. (f) An axial T1 weighted image showing iso-signal intensity. (g) On an axial diffusion-weighted image, the lesion had iso-signal intensity. (h) A maximum intensity projection PET coronal image and (i) a PET/CT fusion image exhibiting focal FDG uptake at the upper pole of the left kidney with a SUV max of 9.4. (j) Hematoxylin and eosin staining indicating an epithelioid granuloma and fibrosis with multinucleated giant cells. FDG,fludeoxyglucose; HU, Hounsfield unit; SUV, standardized uptake value
Figure 1. Case 1: Renal granuloma developing after intravesical bacillus Calmette-Guérin treatment for bladder carcinoma in a 73-year-old male. (a) An axial unenhanced CT image revealing an iso-attenuating mass (37 HU), compared to the renal parenchyma. (b–d) Dynamic contrast-enhanced CT findings showed a gradually enhanced renal mass. The CT attenuation value was 47 HU during the corticomedullary phase (b), 87 HU during the nephrographic phase (c), and 90 HU during the early excretory phase (d). (e) An axial T2 weighted image presenting low signal intensity for the renal lesion on the left kidney. (f) An axial T1 weighted image showing iso-signal intensity. (g) On an axial diffusion-weighted image, the lesion had iso-signal intensity. (h) A maximum intensity projection PET coronal image and (i) a PET/CT fusion image exhibiting focal FDG uptake at the upper pole of the left kidney with a SUV max of 9.4. (j) Hematoxylin and eosin staining indicating an epithelioid granuloma and fibrosis with multinucleated giant cells. FDG,fludeoxyglucose; HU, Hounsfield unit; SUV, standardized uptake valueCC BY · PubMed Central
Figure 2. Case 2: Renal granuloma after intravesical bacillus Calmette-Guérin therapy for bladder carcinoma in a 67-year-old male. (a) An axial unenhanced CT image showing an iso-attenuating mass, compared to the renal parenchyma. (b) Contrast-enhanced CT revealing a homogenously enhanced renal mass. (c) An axial T2 weighted image presenting low signal intensity in the left renal lesion. (d) On the axial diffusion-weighted image, the lesion exhibits iso-signal intensity. (e) A PET/CT fusion image indicating increased FDG uptake at the lesion, with a maximum standardized uptake value of 6.4. (f) Hematoxylin and eosin staining demonstrating epithelioid granuloma and fibrosis with giant cells. FDG, fludeoxyglucose
Figure 2. Case 2: Renal granuloma after intravesical bacillus Calmette-Guérin therapy for bladder carcinoma in a 67-year-old male. (a) An axial unenhanced CT image showing an iso-attenuating mass, compared to the renal parenchyma. (b) Contrast-enhanced CT revealing a homogenously enhanced renal mass. (c) An axial T2 weighted image presenting low signal intensity in the left renal lesion. (d) On the axial diffusion-weighted image, the lesion exhibits iso-signal intensity. (e) A PET/CT fusion image indicating increased FDG uptake at the lesion, with a maximum standardized uptake value of 6.4. (f) Hematoxylin and eosin staining demonstrating epithelioid granuloma and fibrosis with giant cells. FDG, fludeoxyglucoseCC BY · PubMed Central
Figure 3. Case 3: Renal granuloma after intravesical bacillus Calmette-Guérin therapy for bladder carcinoma in a 71-year-old male. (a) An axial unenhanced CT image showing an iso-attenuating mass, compared to the renal parenchyma. (b) Contrast-enhanced CT revealing a heterogeneously enhanced renal mass during the nephrographic phase. (c) An axial T2 weighted image exhibiting heterogeneous and slightly high signal intensity in the left renal lesion. (d) An axial diffusion-weighted image indicating high signal intensity. The pathological specimen [hematoxylin–eosin staining: (e) low-power view, (f) high-power view] provides evidence of a necrotizing granuloma with severe infiltration of macrophages and lymphocytes
Figure 3. Case 3: Renal granuloma after intravesical bacillus Calmette-Guérin therapy for bladder carcinoma in a 71-year-old male. (a) An axial unenhanced CT image showing an iso-attenuating mass, compared to the renal parenchyma. (b) Contrast-enhanced CT revealing a heterogeneously enhanced renal mass during the nephrographic phase. (c) An axial T2 weighted image exhibiting heterogeneous and slightly high signal intensity in the left renal lesion. (d) An axial diffusion-weighted image indicating high signal intensity. The pathological specimen [hematoxylin–eosin staining: (e) low-power view, (f) high-power view] provides evidence of a necrotizing granuloma with severe infiltration of macrophages and lymphocytesCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 11

Metadata

Authors
Narita, K., Akita, H., Kikuchi, E., Nakahara, T., Okuda, S., Nakatsuka, S., Oya, M., & Jinzaki, M.
Affiliations
Keio University (JP)
Corresponding author
Jinzaki, Masahiro
Venue
BJR|case reports
Published
2019-09
Volume
5
Issue
4
Pages
bjrcr.20190012
ISSN
2055-7159 (ISSN-L)
OpenAlex
W2951026902
Cited by
11
References
33
Citations by year
2026: 4 · 2025: 1 · 2023: 2 · 2022: 3 · 2021: 1
FWCI
0.96
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • BJR|case reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Bladder and Urothelial Cancer Treatments
  • Health Sciences › Medicine › Surgery › Urinary and Genital Oncology Studies
  • Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
Keywords
BCG vaccine, intravesical therapy, bladder cancer, granulomatous inflammation, renal fibrosis, diffusion-weighted imaging, FDG uptake, differential diagnosis of renal mass, renal biopsy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.